Teva Pharmaceutical Industries Limited
TEVA
Rank in Stocks
#481
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Share Price
$42.99
Last synced: 2026-11-09
Market Cap
$50.10B
Change (1 day)
2.98%
Change (1 year)
72.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Teva Pharmaceutical Industries Limited (TEVA)
Category
Healthcare
EPS for Teva Pharmaceutical Industries Limited (TEVA)
EPS as of September 2026 TTM: $0.45
According to Teva Pharmaceutical Industries Limited's latest financial reports, its current EPS (TTM) is $0.45. At the end of 2025 the company had an EPS of $1.23, an increase over its 2024 EPS of $-1.45.
EPS history for Teva Pharmaceutical Industries Limited from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.45 | -63.41% |
| 2025 | $1.23 | -184.83% |
| 2024 | $-1.45 | 190.00% |
| 2023 | $-0.50 | -76.42% |
| 2022 | $-2.12 | -657.89% |
| 2021 | $0.38 | -110.44% |
| 2020 | $-3.64 | 295.65% |
| 2019 | $-0.92 | -56.40% |
| 2018 | $-2.11 | -86.82% |
| 2017 | $-16.01 | -22,971.43% |
| 2016 | $0.07 | -96.20% |
| 2015 | $1.84 | -48.60% |
| 2014 | $3.58 | 140.27% |
| 2013 | $1.49 | -33.78% |
| 2012 | $2.25 | -27.42% |
| 2011 | $3.10 | -16.67% |
| 2010 | $3.72 | 62.45% |
| 2009 | $2.29 | 182.72% |
| 2008 | $0.81 | -68.11% |
| 2007 | $2.54 | 252.78% |
| 2006 | $0.72 | -58.38% |
| 2005 | $1.73 | 220.37% |
| 2004 | $0.54 | -58.14% |
| 2003 | $1.29 | 65.38% |
| 2002 | $0.78 | 47.17% |
| 2001 | $0.53 | 82.76% |
| 2000 | $0.29 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 1,344.76% |
DE
|
|
| $6.08 | 1,250.58% |
DE
|
|
| $1.55 | 244.58% |
JP
|
|
| $3.66 | 713.33% |
CH
|
|
| $0.48 | 6.67% |
IN
|
Questions about Teva Pharmaceutical Industries Limited's earnings per share (EPS)
What is Teva Pharmaceutical Industries Limited's earnings per share (EPS)?
Teva Pharmaceutical Industries Limited's earnings per share (EPS) over the last twelve months is $0.45, as of Sep 2026.
What was Teva Pharmaceutical Industries Limited's earnings per share (EPS) in 2025?
In 2025, Teva Pharmaceutical Industries Limited's earnings per share (EPS) was $1.23, compared with $-1.45 in 2024.
How has Teva Pharmaceutical Industries Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Teva Pharmaceutical Industries Limited's earnings per share (EPS) was highest in 2025 ($1.23) and lowest in 2020 ($-3.64).
How does Teva Pharmaceutical Industries Limited's earnings per share (EPS) compare with similar companies?
Teva Pharmaceutical Industries Limited's earnings per share (EPS) ($0.45) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.